HHHFA in COPD Patients, With Chronic Bronchitis

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

December 5, 2022

Study Completion Date

December 5, 2022

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DEVICE

HHHFA Device

Participants will be instructed to use the HHHFA for at least 4 hours during their sleep but will be allowed to use it as long as they want during sleep.

DIAGNOSTIC_TEST

Spirometry

Pre and post spirometry using albuterol.

DIAGNOSTIC_TEST

6-minute walk

6-minute walk

DIAGNOSTIC_TEST

CT scan

CT scan

OTHER

Medical Research Council dyspnea scale (MRC)

MRC questionnaire

OTHER

St. George's Respiratory Questionnaire (SGRQ)

SGRQ questionnaire

OTHER

COPD Assessment Test (CAT)

CAT questionnaire

OTHER

Pittsburgh Sleep Quality Index (PSQI)

PSQI questionnaire

OTHER

CASA-Q

CASA-Q questionnaire

OTHER

Spirehealth Tag Device

Subjects will wear the Spirehealth Tag Device to measure heart rate, respiratory rate, sleep time, physical activity (movement), and calories burned with activity.

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

American Thoracic Society

OTHER

lead

Spyridon Fortis

OTHER

NCT03959982 - HHHFA in COPD Patients, With Chronic Bronchitis | Biotech Hunter | Biotech Hunter